Paper9730896
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.
Pessino A and 7 others. J Exp Med, 1998. Cited by 465 papers, by iCite.
Cite this record
ConductScience Library. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. Papers, record 9730896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9730896
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Immunoglobulins | Major topic |
| Killer Cells, Natural | Major topic |
| Multigene Family | Major topic |
| Receptors, Immunologic | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Blotting, Southern | |
| Cattle | |
| Cell Line | |
| Chromosome Mapping | |
| Cloning, Molecular | |
| DNA, Complementary | |
| Dogs | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Molecular Sequence Data | |
| Natural Cytotoxicity Triggering Receptor 1 | |
| Organ Specificity | |
| Rabbits | |
| Rats | |
| Transcription, Genetic | |
| Tumor Cells, Cultured |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7749980 | Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. | Immunity | 1995 | https://conductscience.org/library/papers/7749980 | PubMed |
| 2 | 7716543 | Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. | Science | 1995 | https://conductscience.org/library/papers/7716543 | PubMed |
| 3 | 7650491 | Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. | J Exp Med | 1995 | https://conductscience.org/library/papers/7650491 | PubMed |
| 4 | 8627176 | The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. | J Exp Med | 1996 | https://conductscience.org/library/papers/8627176 | PubMed |
| 5 | 8717527 | Receptors for HLA class-I molecules in human natural killer cells. | Annu Rev Immunol | 1996 | https://conductscience.org/library/papers/8717527 | PubMed |
| 6 | 8760804 | The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760804 | PubMed |
| 7 | 8765026 | A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. | Eur J Immunol | 1996 | https://conductscience.org/library/papers/8765026 | PubMed |
| 8 | 8769479 | CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. | Immunity | 1996 | https://conductscience.org/library/papers/8769479 | PubMed |
| 9 | 8948436 | Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. | Biochem J | 1995 | https://conductscience.org/library/papers/8948436 | PubMed |
| 10 | 9045931 | The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. | Eur J Immunol | 1997 | https://conductscience.org/library/papers/9045931 | PubMed |
| 11 | 9133416 | Natural killer cells: from no receptors to too many. | Immunity | 1997 | https://conductscience.org/library/papers/9133416 | PubMed |
| 12 | 9151699 | A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. | J Exp Med | 1997 | https://conductscience.org/library/papers/9151699 | PubMed |
| 13 | 9164921 | Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. | J Immunol | 1997 | https://conductscience.org/library/papers/9164921 | PubMed |
| 14 | 9174606 | The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. | Eur J Immunol | 1997 | https://conductscience.org/library/papers/9174606 | PubMed |
| 15 | 9259559 | A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. | Curr Biol | 1997 | https://conductscience.org/library/papers/9259559 | PubMed |
| 16 | 9278324 | Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. | J Immunol | 1997 | https://conductscience.org/library/papers/9278324 | PubMed |
| 17 | 9285412 | LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. | Immunity | 1997 | https://conductscience.org/library/papers/9285412 | PubMed |
| 18 | 9314561 | p46, a novel natural killer cell-specific surface molecule that mediates cell activation. | J Exp Med | 1997 | https://conductscience.org/library/papers/9314561 | PubMed |
| 19 | 9490415 | Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. | Nature | 1998 | https://conductscience.org/library/papers/9490415 | PubMed |
| 20 | 9485212 | The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. | Eur J Immunol | 1998 | https://conductscience.org/library/papers/9485212 | PubMed |
Cited by203
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 465 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41761987 | A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation. | Cell Transplant | 2026 | https://conductscience.org/library/papers/41761987 | PubMed |
| 41304903 | Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304903 | PubMed |
| 40650066 | Rendering NK Cells Antigen-Specific for the Therapy of Solid Tumours. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650066 | PubMed |
| 40318632 | Characterization and comparative analysis of multifunctional natural killer cell engagers during antitumor responses. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40318632 | PubMed |
| 39845286 | Research Progress of NK Cells in Glioblastoma Treatment. | Onco Targets Ther | 2025 | https://conductscience.org/library/papers/39845286 | PubMed |
| 39612130 | Advancements in the Study of the Immune Molecule NKp46 in Immune System-related Diseases. | Clin Rev Allergy Immunol | 2024 | https://conductscience.org/library/papers/39612130 | PubMed |
| 39511139 | Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39511139 | PubMed |
| 39246620 | The Multifaceted Roles of NK Cells in the Context of Murine Cytomegalovirus and Lymphocytic Choriomeningitis Virus Infections. | Immune Netw | 2024 | https://conductscience.org/library/papers/39246620 | PubMed |
| 39163262 | An engineered NKp46 antibody for construction of multi-specific NK cell engagers. | Protein Eng Des Sel | 2024 | https://conductscience.org/library/papers/39163262 | PubMed |
| 38842526 | Five decades of natural killer cell discovery. | J Exp Med | 2024 | https://conductscience.org/library/papers/38842526 | PubMed |
| 38383621 | Natural killer cell therapies. | Nature | 2024 | https://conductscience.org/library/papers/38383621 | PubMed |
| 38240638 | Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells. | Immunohorizons | 2024 | https://conductscience.org/library/papers/38240638 | PubMed |
| 38203786 | Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38203786 | PubMed |
| 38007241 | Therapeutic avenues for γδ T cells in cancer. | J Immunother Cancer | 2023 | https://conductscience.org/library/papers/38007241 | PubMed |
| 37435079 | Complex interactions of cellular players in chronic Graft-versus-Host Disease. | Front Immunol | 2023 | https://conductscience.org/library/papers/37435079 | PubMed |
| 37275911 | Natural killer cells- from innate cells to the discovery of adaptability. | Front Immunol | 2023 | https://conductscience.org/library/papers/37275911 | PubMed |
| 37190251 | The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190251 | PubMed |
| 37048069 | Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3. | Cells | 2023 | https://conductscience.org/library/papers/37048069 | PubMed |
| 36768432 | Natural Killer Cell-Based Immunotherapy against Glioblastoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768432 | PubMed |
| 36419901 | NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia. | Front Oncol | 2022 | https://conductscience.org/library/papers/36419901 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data4
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9730896
GET https://conductscience.org/api/papers/v1/9730896/references?page=2